Английская Википедия:Dolutegravir/rilpivirine

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Infobox drug

Dolutegravir/rilpivirine, sold under the brand name Juluca, is a fixed-dose combination antiretroviral medication for the treatment of HIV/AIDS.[1][2] It contains the medicines dolutegravir and rilpivirine.[2] It is taken by mouth.[2]

The most common adverse reactions (of all severity grades) are diarrhea and headache.[2]

Dolutegravir/rilpivirine was approved for use in the United States in November 2017,[2][3][4] and for use in the European Union in May 2018.[5]

Medical uses

Dolutegravir/rilpivirine is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 copies/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor or integrase inhibitor.[5]

References

Шаблон:Reflist

External links

Шаблон:Antiretroviral drug Шаблон:Portal bar


Шаблон:Antiinfective-drug-stub

  1. Шаблон:Cite journal
  2. 2,0 2,1 2,2 2,3 2,4 Шаблон:Cite web
  3. Шаблон:Cite web
  4. Шаблон:Cite web
  5. 5,0 5,1 Шаблон:Cite web Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.